Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on September 14, 2026. The report details the formal implementation of a reverse stock split previously authorized by stockholders at a special meeting held on April 20, 2026.
Key Financial Metrics
This filing is a corporate action report and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Reverse Stock Split: The Board of Directors approved a one-for-fifteen (1:15) reverse stock split of the Company's Common Stock.
- Effective Date: The split became effective at 12:01 am Eastern Time on September 17, 2026.
- Share Reclassification: Every 15 shares of Common Stock issued and outstanding prior to the effective time were automatically reclassified into 1 share of Common Stock.
- Derivative Adjustments: The number of shares issuable upon exercise or vesting of outstanding stock options and warrants was reduced proportionately, with a corresponding increase in exercise and conversion prices.
- Fractional Shares: No fractional shares were issued; stockholders entitled to fractional shares received cash payments in lieu thereof.
- Trading Details: Trading resumed on The Nasdaq Capital Market on a split-adjusted basis on September 17, 2026, under the new CUSIP number 47010C 854.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure regarding the mechanics of the reverse stock split. The Company issued a press release on September 15, 2026, announcing the effectuation of the split, which is furnished as an exhibit but not deemed "filed" for liability purposes.
Investor Verification Checklist
- Verify the new CUSIP number (47010C 854) for trading purposes.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Review the adjusted exercise prices and share counts for any outstanding stock options or warrants.
- Check for cash payments received in lieu of fractional shares if applicable.
- Monitor the stock price performance on The Nasdaq Capital Market following the September 17, 2026 effective date.